Expert Shares Her Tips for Diagnosing, Treating Onychomycosis Expert Shares Her Tips for Diagnosing, Treating Onychomycosis
"We need to be antifungal stewards, because resistant dermatophytes are coming," says Dr Boni E. Elewski.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 23, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Hallux Reaches Enrollment Target in Onychomycosis Trial
Multi-Site Phase 2A Study Evaluates Novel Gel For Subungual Application(PRWeb February 28, 2023)Read the full story at https://www.prweb.com/releases/2023/02/prweb19177844.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 28, 2023 Category: Pharmaceuticals Source Type: news
Hallux Inc. Opens Third Clinical Site to Evaluate Novel Onychomycosis...
Front Range Foot and Ankle Clinic begins screening patients for HSG-201(PRWeb September 22, 2022)Read the full story at https://www.prweb.com/releases/2022/09/prweb18904730.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 22, 2022 Category: Pharmaceuticals Source Type: news
Zydus gets USFDA nod to market generic antifungal medication
Efinaconazole is an antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes. The drug will be manufactured at the group's topical manufacturing facility in Ahmedabad. As per IQVIA data, Efinaconazole topical solution had annual sales of USD 292 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2022 Category: Pharmaceuticals Source Type: news
Picture of Ringworm Tinea Unguium (Onychomycosis)
Title: Picture of Ringworm Tinea Unguium (Onychomycosis)Category: ImagesCreated: 12/14/2010 7:03:00 PMLast Editorial Review: 6/1/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 1, 2022 Category: Dermatology Source Type: news
Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board of Directors
Veteran Bridgewater partner brings capital formation experience to company as it pioneers subungal treatment for tough-to-cure onychomycosis.(PRWeb May 18, 2022)Read the full story at https://www.prweb.com/releases/2022/05/prweb18679990.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 18, 2022 Category: Pharmaceuticals Source Type: news
Corns, Calluses and Properly Fitting Children ’ s Shoes
Discussion
Probably the most common foot problem is foot pain or skin problems. This can be due to chronic and acute trauma, mobility issues, normal development, activities and footwear.
Common foot problems include:
Acute trauma is probably one of the most common reason patients and families seek care for is pain after acute trauma. Children prior to full puberty with acute trauma may have a growth plate fractures or Salter-Harris fractures which can be reviewed here.
Apophysitis and tendonitis are common overuse injuries where there is irritation of the tendon and its insertion points. Chronic overuse can also lead to f...
Source: PediatricEducation.org - March 28, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
VT-1161 Oral Tablets in the Treatment of Toenail Onychomycosis VT-1161 Oral Tablets in the Treatment of Toenail Onychomycosis
A new oral antifungal, VT-1161, shows promise in the treatment of difficult-to-treat subungual onychomycosis of the toenail.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Daily Efinaconazole for Dermatophyte Toenail Onychomycosis Daily Efinaconazole for Dermatophyte Toenail Onychomycosis
This interim data indicates the effectiveness and safety of efinaconazole 10% solution use beyond 12 months. Use for up to 24 months appears to remain safe even for elderly patients.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Ghana: Oral Treatment of Onychomycosis (Tinea Unguium)
[Ghanaian Times] "I have finger nail infection. I am told it is a fungal infection called Tinea. I have used Griseofulvin in the past. Recently I was put on Itraconazole capsulesby my healthcare provider. My healthcare provider asked me take 200mg twice daily for 1 week, repeat the same for another 1 week the second month and do another 1 week for the third month. The dosing is unusual for me. Will it work?". Yes it will work. It is called Pulse therapy. The alternative is to take 200mg daily for 3 months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 9, 2020 Category: African Health Source Type: news
Pulse vs Continuous Therapy for Toenail Onychomycosis Pulse vs Continuous Therapy for Toenail Onychomycosis
Pulse and continuous regimens -- with terbinafine or itraconazole -- are equally safe and effective for dermatophyte toenail onychomycosis, results from a systematic review and meta-analysis show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news
Monotherapy for Toenail Onychomycosis Monotherapy for Toenail Onychomycosis
Which treatment for fungal nail infections works best? This meta-analysis examined evidence for oral, topical, combination and device-based treatments for toenail onychomycosis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Moberg Pharma Meets Primary Endpoint for MOB-015 in a Phase 3 Study for the Treatment of Onychomycosis
STOCKHOLM, Dec. 9, 2019 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) met the primary endpoint as well as key secondary endpoints in the North American Phase 3 study including 365 pat... Biopharmaceuticals Moberg Pharma, terbinafine, onychomycosis, nail fungus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 9, 2019 Category: Pharmaceuticals Source Type: news
Onychomycosis
Fungal Nail Infection (Onychomycosis) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 7, 2019 Category: General Medicine Source Type: news
What Are Treatment Options for Pediatric Onycomycosis?
Discussion
Onycomycosis is a fungal infection of the nails. It has a world-wide prevalence of 0.3% with some geographical variations such as in the U.S. it is 0.44%. It is an uncommon problem especially in children. It is very uncommon in those under 6 years and only very sporadic case reports in those under 2 years. The lower incidence is felt to be due to children’s faster nail growth, smaller surface to infect, reduced exposure to fungi, lower prevalence of tinea pedis and especially less cumulative trauma. Onycomycosis is more common in families (unsure if this is due to genetic factors or family members having m...
Source: PediatricEducation.org - April 8, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
